Literature DB >> 19835816

Robotic radical trachelectomy after supracervical hysterectomy for cut-through endometrial adenocarcinoma stage IIB: a case report.

Vanna Zanagnolo1, Javier F Magrina.   

Abstract

We report on a patient with a cut-through endometrial malignancy after supracervical hysterectomy treated by radical trachelectomy and staging via a robotic approach. A 58-year-old patient with incidental finding of a stage IIB G1 endometrial adenocarcinoma after a supracervical hysterectomy underwent robotic radical trachelectomy, bilateral pelvic lymphadenectomy, and ileal resection with anastomosis. The operative time was 360 minutes, and blood loss was 100mL. The pathology report revealed no evidence of residual disease. The patient remains disease-free 18 months after her robotic procedure. Robotic radical trachelectomy and pelvic lymphadenectomy appear to be feasible and safe for the treatment of endometrial malignancy discovered after supracervical hysterectomy. We suggest use of the terms partial radical trachelectomy for fertility preservation procedures and radical trachelectomy after subtotal hysterectomy for the complete radical removal of the cervix.

Entities:  

Mesh:

Year:  2009        PMID: 19835816     DOI: 10.1016/j.jmig.2009.06.019

Source DB:  PubMed          Journal:  J Minim Invasive Gynecol        ISSN: 1553-4650            Impact factor:   4.137


  2 in total

1.  Sentinel node mapping in high risk endometrial cancer after laparoscopic supracervical hysterectomy with morcellation.

Authors:  Alessandro Buda; Cuzzocrea Marco; Carlotta Dolci; Federica Elisei; Romina Baldo; Luca Locatelli; Rodolfo Milani; Cristina Messa
Journal:  Int J Surg Case Rep       Date:  2013-07-16

2.  Critical analysis of cases of endometrial carcinoma of the uterine corpus incidentally diagnosed after incomplete surgery for other indications. Three case reports and a review of the literature.

Authors:  Małgorzata Gajewska; Mirosław Wielgoś; Grzegorz Panek
Journal:  Prz Menopauzalny       Date:  2014-11-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.